Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > AGM predictions

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon May 06, 2024 11:37am

165 Views

Post# 36025010

AGM predictions

So any predictions for the AGM outcome on Thursday. Will we assist to a sequel of last year with Dawn sitting next to our wonder boy putting a deathrow face on once again. Minus 94% over 5 years... like SPCEO said so well... Technical bankrupcy. Anyway, hope we make it to a better place and that it's under the helm of other BOD and management... sincerely. Hope they go away.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks